written on 27.02.2014

CHMP disregards PRAC call to suspend Servier's Protelos in EU

TAGS: ,

The European Medicines Agency says that Servier's osteoporosis treatment Protelos/Osseor (strontium ranelate) should remain on the market with additional restrictions, even though its Pharmacovigilance Risk Assessment Committee (PRAC) recommended in…